| Bioactivity | Moricizine Hydrochloride (EN 313) is an orally active Class I antiarrhythmic agent. Moricizine Hydrochloride decreases the maximum rate of phase 0 depolarization; increases rates of phase 2 and 3 repolarization, decreases action potential duration, and decreases effective refractory period[1]. |
| Name | Moricizine Hydrochloride |
| CAS | 29560-58-5 |
| Formula | C22H26ClN3O4S |
| Molar Mass | 463.98 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Bigger JT Jr. Cardiac electrophysiologic effects of moricizine hydrochloride. Am J Cardiol. 1990 Feb 20;65(8):15D-20D; discussion 68D-71D. |
Moricizine Hydrochloride
CAS: 29560-58-5 F: C22H26ClN3O4S W: 463.98
Moricizine Hydrochloride (EN 313) is an orally active Class I antiarrhythmic agent. Moricizine Hydrochloride decreases t
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.